Clinical Trial: The mechanism by which ciprofol inhibits neuronal ferroptosis by affecting NETs release and ameliorates postoperative cognitive dysfunction in patients (China)

Posted On: 2026-08-25

China, Aug. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The mechanism by which ciprofol inhibits neuronal ferroptosis by affecting NETs release and ameliorates postoperative cognitive dysfunction in patients'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130755

Registration Time: 2026/08/24

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of Wenzhou Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=289212

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: The mechanism by which ciprofol inhibits neuronal ferroptosis by affecting NETs release and ameliorates postoperative cognitive dysfunction in patients (China)